Delivery Order SPE2DB22D3009-SPE2DB25FBF17
- Not listed
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose format (50 units) valued at $2,397.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,719.02 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 unit dose vials) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,376.52 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,845.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) with a completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Refresh Plus 0.5% eye drops (30-count units) with a contract value of $1,476.04. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, demonstrating...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF17Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Refresh Plus 0.5% Eye Drops (50-unit packages) under a firm fixed-price contract valued at $7,137.89. This is a non-set-aside competitive award with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. The company has demonstrated consistent capability to fulfill federal procurement requirements through open competition, as evidenced by its extensive contract award history with the DLA Medical Supply Chain. This delivery order for ophthalmological products aligns with the company's established role as a prime vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet global military healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/16/25 |